Are you interested in monitoring the US venture capital funding in our sector?  Look no further than PwC’s MoneyTree report. The company offers a quarterly report that breaks down deals by quarter, stages and venture capital outlook for the life science sector. The most recent report, Q316, indicates that venture capitalists invested $2.5 billion in 156 life science companies during the third quarter which was down from $3.0 billion in 210 deals during the same quarter of 2015. The silver lining was that the average deal size increase...

Please reload

Follow Us
  • LinkedIn Social Icon
  • Twitter Basic Square
  • Facebook Social Icon

© 2020 The Sonder Group